Cincinnati, Ohio Pharmaceutical injury lawyer and product liability attorney reviewing Low T clinic heart attack and pulmonary embolism risks and Testosterone Replacement medication complications in male plaintiffs nationwide.


Testosterone replacement and Low T clinic promise great results but there are several health risks involved, including heart attack, pulmonary embolism and stroke risks for Low-T patients. Dangerous testosterone medications are being investigated by the FDA, and experts urge caution for patients.

Many men suffer from low testosterone levels, and doctors have recommended testosterone replacement medications. But low-T drugs may lead to dangerous side effects like blood clots and heart attacks. Following Low T clinic injury, plaintiffs have filed lawsuits alleging low-testosterone drugs cause serious heart problems, pulmonary embolism, blood clots and other injury.

Attorneys argue the drug manufacturers of testosterone replacement therapy drugs are liable for their failure to warn of certain complications like stroke and heart attack, as well as negligence in marketing, branding, and consumer fraud for concealing information about product safety findings.

According to the Mayo Clinic, taking testosterone supplements for low levels naturally caused by aging is not advisable, which is also the position of the U.S. Food and Drug Administration.

The FDA is investigating the safety of low-T therapy after two studies indicated a potential for an increase in the risk of heart problems. In 2014, the FDA issued a Safety Announcement and a requirement for general label warnings of the increased risk of pulmonary embolism and blood clots.

In 2015, the U.S. Food and Drug Administration (FDA) began recommending that testosterone be approved only for people who have low testosterone due to certain medical conditions.

The FDA warnings are meant to alert the public that taking testosterone is not without risks. The benefits and safety are still undecided by the medical science community. Thus, doctors and patients are left to risk heart attacks and blood clots linked to testosterone replacements.

Joe Lyon is an experienced Cincinnati, Ohio drug injury attorney and pharmaceutical lawyer representing injured plaintiffs nationwide in testosterone therapy Low T injury lawsuits.


Venous thromboembolism (VTE) & Testosterone Therapy


Recent studies have concluded that testosterone therapy is associated with an increase in the short-term risk for venous thromboembolism (VTE) among men with and without hypogonadism. Researchers are concerned the association between testosterone therapy and blood clots could be more pronounced among younger men.

The study, published in the Journal of Clinical Medicine, BMJ and JAMA, assessed the time of thrombotic thrombotic events like VTE after beginning testosterone therapy (TT) in men who sustained VTE. Thrombotic events were greatest at around 3 months after starting testosterone replacement therapy, with a decline in adverse health events by 10 months.


Low T Clinic Injury & Low-testosterone Symptoms


Low testosterone, or male hypogonadism, is a condition in which the testes do not produce enough testosterone, the male sex hormone. Testosterone helps maintain and develop sexual features, muscle mass, levels of red blood cells, bone density, sense of well-being, and sexual function.

But low testosterone levels are very common with around 40 percent of men aged 45 and older with low levels.


Symptoms of low testosterone may include:

  • Low sex drive
  • Erectile dysfunction
  • Depression
  • Difficulties concentrating
  • Memory loss
  • Fatigue
  • Loss of muscular strength
  • A decrease in hemoglobin
  • A decrease in body hair
  • Thinning of the bones (osteoporosis)
  • Increased body fat
  • Breast development (gynecomastia)

Testosterone Therapy Heart Attacks


Based on FDA findings, some testosterone products may increase the risk of cardiac events, blood clots, heart attacks and strokes. Low T Clinic health care professionals have a duty to warn patients of hormone therapy risks.

Testosterone manufacturers are now required to conduct clinical trials to confirm the increased risk of heart attack, pulmonary embolism or stroke. Patients using testosterone treatments should seek medical attention if symptoms of a heart attack or stroke are present, including:

  • Chest pain
  • Shortness of breath or trouble breathing
  • Weakness in one part or one side of the body
  • Slurred speech

Testosterone Safety Warning


Some studies have indicated that starting testosterone treatment is associated with an increased risk of pulmonary embolism and heart attack in patients, which peaks within six months and declines if therapy is discontinued.

Hormone replacement has its known risks, and when testosterone replacement therapy is undergone by patients, they must be aware of the injury risk, including an added risk of blood clots and cardiac events. The FDA issued a warning in 2015 that testosterone therapy can potentially cause blood clots in men.

The U.S. Food and Drug Administration cautioned doctors and patients that some testosterone products are approved only for men who have low testosterone caused by specific medical conditions.

For years, consumer safety attorneys have been concerned that Low T clinics have been marketing testosterone replacement therapy to those who do not need it. Not only do some patients not benefit from a Low T therapy, the treatment may increase heart attack and pulmonary embolism risks.


Testosterone Replacement Treatments


The benefits and long-term safety of testosterone therapies have not been well-established, thus concerning patient safety lawyers across the country. With the reports of heart attacks and blood clots experienced following Low T treatments, testosterone therapy lawsuits have been on the rise.

The FDA has worked to provide some warnings. The agency required that testosterone replacement manufacturers change their labeling to clarify the specific approved uses. FDA requirements also include labeling about a possible increased risk of heart attacks, blood clots and strokes.

Doctors at Low T clinics have been urged to only prescribe testosterone therapy to men with low testosterone levels caused by certain medical conditions.

FDA-approved replacement therapies are for men with a condition called hypogonadism, which means low testosterone levels are due to disorders of the testicles, pituitary gland, or brain. The FDA is well-aware that testosterone is used regularly in to relieve low testosterone symptoms due to aging. The benefits and safety of this use is still unknown.


Testosterone Treatment Options


In males, the testicles make a hormone called testosterone. This hormone helps form male sexual characteristics and plays a role in maintaining muscle mass and normal bone density. Testosterone production starts to naturally decline around age 30.

Blood tests can measure testosterone levels and can indicate a low, high, or normal range. Testosterone therapy may be necessary if the levels drop significantly if for reasons other than aging. Testosterone therapies and Low T treatments are available as an injection, a patch, a gel, or a tablet placed in the mouth. Hormone replacement therapy may have many risks, including cardiovascular health risks.


Joe Lyon is a highly-rated Cincinnati drug injury lawyer and Ohio product liability attorney investigating Low T testosterone therapy injury lawsuits for plaintiffs nationwide.

If you or someone you know has suffered a heart attack or pulmonary embolism following testosterone replacement therapy, please contact the Lyon Firm at 800.513.2403 to learn about your legal options.